Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Antiparasitic Agents

Insgesamt 2889 ergebnisse

NCT01445938

Beendet

Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria

Bedingungen: Malaria
NCT03598842

Anmeldung auf Einladung

Tuberculosis - Learning the Impact of Nutrition

Bedingungen: Tuberculosis; Malnutrition; Helminth Infection
NCT02841215

Rekrutierung

Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies

Bedingungen: Gale; Severe Forms of Scabies; Oral Parasitic Drug; Ivermectin
NCT03553615

Zurückgezogen

Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis

Bedingungen: Atopic Dermatitis
NCT03605758

Rekrutierung

Treatment of Strongyloides Infection

Bedingungen: Strongyloides Stercoralis Infection; Strongyloidiasis
NCT01070277

Unbekannter Status

Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea

Bedingungen: Chronic Diarrhea; Abdominal Pain; Bloating
NCT00441285

Abgeschlossen

Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)

Bedingungen: Neurocysticercosis; Epilepsy
NCT03474276

Abgeschlossen

Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old

Bedingungen: Moderate Acute Malnutrition
NCT00002158

Unbekannter Status

A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis

Bedingungen: Cryptosporidiosis; HIV Infections
NCT04463264

Rekrutierung

Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

Bedingungen: COVID-19
NCT02234570

Abgeschlossen

Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole

Bedingungen: Neurocysticercosis
NCT03950037

Noch nicht rekrutiert

SANCC: Clinical Trial Early Intervention

Bedingungen: Subarachnoid Neurocysticercosis
NCT02046200

Abgeschlossen

Development of Ivermectin for Alcohol Use Disorders

Bedingungen: Alcohol Use Disorder
NCT04701710

Abgeschlossen

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan

Bedingungen: Covid19; SARS (Severe Acute Respiratory Syndrome)
NCT03578679

Abgeschlossen

Treatment of Pediculosis (Head Lice) in Senegal

Bedingungen: Pediculoses
NCT04681053

Rekrutierung

Inhaled Ivermectin and COVID-19

Bedingungen: COVID-19
NCT04405843

Abgeschlossen

Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)

Bedingungen: COVID-19
NCT03967054

Rekrutierung

Repeat Ivermectin Mass Drug Administrations for MALaria Control II

Bedingungen: Malaria
NCT04429711

Rekrutierung

Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Bedingungen: COVID-19
NCT03177993

Abgeschlossen

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji

Bedingungen: Lymphatic Filariases; Scabies; Impetigo; Soil Transmitted Helminths
NCT03257943

Abgeschlossen

A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

Bedingungen: Lice; Head Lice
NCT04739410

Abgeschlossen

Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients

Bedingungen: Covid19
NCT03301649

Abgeschlossen

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Bedingungen: Head Lice
NCT03052998

Abgeschlossen

Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy

Bedingungen: Ivermectin; Onchocerciasis; Epilepsy
NCT04703205

Rekrutierung

Study in COvid-19 Patients With iveRmectin (CORVETTE-01)

Bedingungen: Covid19